ENTRY       D10308                      Drug
NAME        Baricitinib (JAN/USAN/INN);
            Olumiant (TN)
PRODUCT     OLUMIANT (Eli Lilly and Company)
  OTHER     BARICITINIB (Eli Lilly and Company)
FORMULA     C16H17N7O2S
EXACT_MASS  371.1164
MOL_WEIGHT  371.4169
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG02020  JAK inhibitor
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
             DG02860  SLC22A8 substrate
             DG03002  SLC47A2 substrate
REMARK      Therapeutic category: 3999
            ATC code: L04AA37
            Product: D10308<JP/US>
EFFICACY    Anti-inflammatory, Antirheumatic, Immunosuppressant, Janus kinase (JAK) inhibitor
  DISEASE   Rheumatoid arthritis [DS:H00630]
            Coronavirus disease 2019 [DS:H02398]
            Alopecia areata [DS:H01158]
COMMENT     Treatment of autoimmune diseases, inflammatory disease, rheumatoid arthritis
TARGET      JAK1 [HSA:3716] [KO:K11217]
            JAK2 [HSA:3717] [KO:K04447]
  PATHWAY   hsa04062(3717)  Chemokine signaling pathway
            hsa04380(3716)  Osteoclast differentiation
            hsa04630(3716+3717)  JAK-STAT signaling pathway
            hsa05171(3716)  Coronavirus disease - COVID-19
METABOLISM  Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLC22A8 [HSA:9376], SLC47A2 [HSA:146802]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA37 Baricitinib
                  D10308  Baricitinib (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               JAK Inhibitors
                Baricitinib
                 D10308  Baricitinib (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D10308  Baricitinib (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                D10308  Baricitinib
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D10308  Baricitinib
             Transporter substrate
              DG01665  ABCB1 substrate
               D10308  Baricitinib
              DG01913  ABCG2 substrate
               D10308  Baricitinib
              DG02860  SLC22A8 substrate
               D10308  Baricitinib
              DG03002  SLC47A2 substrate
               D10308  Baricitinib
            Drug classes [BR:br08332]
             Immunological agent
              DG02020  JAK inhibitor
               D10308  Baricitinib
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D10308  Baricitinib
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D10308  Baricitinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               JAK family
                JAK1
                 D10308  Baricitinib (JAN/USAN/INN) &lt;JP/US&gt;
                JAK2
                 D10308  Baricitinib (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10308
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10308
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10308
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10308
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D10308
DBLINKS     CAS: 1187594-09-7
            PubChem: 163312339
            ChEBI: 95341
            PDB-CCD: 3JW
ATOM        26
            1   C8y C    21.8059  -18.3269
            2   C8y C    21.8059  -19.7308
            3   N5x N    20.6126  -20.4327
            4   C8x C    19.3491  -19.7308
            5   N5x N    19.3491  -18.3269
            6   C8y C    20.6126  -17.6250
            7   C8x C    23.1396  -17.9057
            8   C8x C    23.9819  -19.0288
            9   N4x N    23.1396  -20.1519
            10  C8y C    20.6126  -16.2211
            11  C8x C    19.4895  -15.3787
            12  N4y N    19.9107  -14.1152
            13  N5x N    21.3146  -14.1152
            14  C8x C    21.7357  -15.3787
            15  C1z C    18.7174  -13.4133
            16  C1x C    17.8049  -12.3604
            17  N1y N    16.7519  -13.2729
            18  C1x C    17.6645  -14.3258
            19  C1b C    19.6299  -12.3604
            20  C3b C    21.1040  -12.3604
            21  N3a N    22.5079  -12.3604
            22  S4a S    15.3481  -13.2729
            23  O3c O    15.3481  -11.8690
            24  O3c O    15.3481  -14.6768
            25  C1b C    13.9442  -13.2729
            26  C1a C    13.2422  -12.0572
BOND        29
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 2
            9     8   9 1
            10    2   9 1
            11    6  10 1
            12   10  11 2
            13   11  12 1
            14   12  13 1
            15   13  14 2
            16   10  14 1
            17   15  12 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   15  18 1
            22   15  19 1
            23   19  20 1
            24   20  21 3
            25   17  22 1
            26   22  23 2
            27   22  24 2
            28   22  25 1
            29   25  26 1
///
